Ron Alcalay

885 total citations
34 papers, 377 citations indexed

About

Ron Alcalay is a scholar working on Immunology, Molecular Biology and Biotechnology. According to data from OpenAlex, Ron Alcalay has authored 34 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 13 papers in Molecular Biology and 11 papers in Biotechnology. Recurrent topics in Ron Alcalay's work include Toxin Mechanisms and Immunotoxins (15 papers), Transgenic Plants and Applications (11 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Ron Alcalay is often cited by papers focused on Toxin Mechanisms and Immunotoxins (15 papers), Transgenic Plants and Applications (11 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Ron Alcalay collaborates with scholars based in Israel, Italy and Germany. Ron Alcalay's co-authors include Ohad Mazor, Chanoch Kronman, Tal Noy-Porat, Tamar Sabo, Eyal Epstein, Ronit Rosenfeld, Yoav Gal, Adva Mechaly, Anita Sapoznikov and Reut Falach and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Nano Letters.

In The Last Decade

Ron Alcalay

33 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ron Alcalay Israel 13 217 149 132 67 63 34 377
Joanne M. O’Hara United States 12 396 1.8× 113 0.8× 327 2.5× 34 0.5× 39 0.6× 16 457
Hugh Haydon United States 7 71 0.3× 261 1.8× 308 2.3× 43 0.6× 59 0.9× 7 377
Tal Noy-Porat Israel 11 75 0.3× 117 0.8× 54 0.4× 32 0.5× 44 0.7× 21 260
Audrey Y‐H. Teh United Kingdom 13 122 0.6× 273 1.8× 324 2.5× 82 1.2× 57 0.9× 18 423
Julia Pinkhasov United States 9 241 1.1× 269 1.8× 241 1.8× 20 0.3× 44 0.7× 9 493
Shuhei Hashiguchi Japan 13 103 0.5× 161 1.1× 36 0.3× 117 1.7× 20 0.3× 27 389
Lotte B. Westerhof Netherlands 11 106 0.5× 120 0.8× 105 0.8× 18 0.3× 28 0.4× 15 376
Bahne Stechmann France 4 111 0.5× 168 1.1× 68 0.5× 9 0.1× 43 0.7× 8 332
Kuo‐Shiang Liao Taiwan 9 65 0.3× 189 1.3× 32 0.2× 36 0.5× 51 0.8× 19 331
Hassan Chaabihi France 11 43 0.2× 224 1.5× 64 0.5× 81 1.2× 29 0.5× 14 358

Countries citing papers authored by Ron Alcalay

Since Specialization
Citations

This map shows the geographic impact of Ron Alcalay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron Alcalay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron Alcalay more than expected).

Fields of papers citing papers by Ron Alcalay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ron Alcalay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron Alcalay. The network helps show where Ron Alcalay may publish in the future.

Co-authorship network of co-authors of Ron Alcalay

This figure shows the co-authorship network connecting the top 25 collaborators of Ron Alcalay. A scholar is included among the top collaborators of Ron Alcalay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ron Alcalay. Ron Alcalay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alcalay, Ron, et al.. (2025). Purification of a Fc-Fusion Protein with [Bathophenathroline:metal] Complexes. Antibodies. 14(1). 11–11.
2.
3.
Sapoznikov, Anita, Amir Ben‐Shmuel, Ron Alcalay, et al.. (2024). Short- and long-term outcomes of pulmonary exposure to a sublethal dose of ricin in mice. Scientific Reports. 14(1). 11637–11637. 1 indexed citations
4.
Tamir, Hadas, Tal Noy-Porat, Sharon Melamed, et al.. (2024). Synergistic effect of two human-like monoclonal antibodies confers protection against orthopoxvirus infection. Nature Communications. 15(1). 3265–3265. 10 indexed citations
5.
Levy, Yinon, Ron Alcalay, Anat Zvi, et al.. (2022). Immunodominant Linear B-Cell Epitopes of SARS-CoV-2 Spike, Identified by Sera from K18-hACE2 Mice Infected with the WT or Variant Viruses. Vaccines. 10(2). 251–251. 4 indexed citations
6.
Mechaly, Adva, Ron Alcalay, Eyal Epstein, et al.. (2022). Highly Specific Monoclonal Antibody Targeting the Botulinum Neurotoxin Type E Exposed SNAP-25 Neoepitope. Antibodies. 11(1). 21–21. 5 indexed citations
7.
Rosenfeld, Ronit, Ron Alcalay, Anat Zvi, et al.. (2022). Centaur antibodies: Engineered chimeric equine-human recombinant antibodies. Frontiers in Immunology. 13. 942317–942317. 4 indexed citations
8.
Noy-Porat, Tal, Ron Alcalay, Adva Mechaly, et al.. (2021). Characterization of antibody-antigen interactions using biolayer interferometry. STAR Protocols. 2(4). 100836–100836. 17 indexed citations
9.
Rosenfeld, Ronit, Oliver C. Grant, Ron Alcalay, et al.. (2020). Directed Evolution of Therapeutic Antibodies Targeting Glycosylation in Cancer. Cancers. 12(10). 2824–2824. 17 indexed citations
10.
Gal, Yoav, Anita Sapoznikov, Reut Falach, et al.. (2020). Equal Neutralization Potency of Antibodies Raised against Abrin Subunits. SHILAP Revista de lepidopterología. 9(1). 4–4. 4 indexed citations
11.
Mechaly, Adva, Uri Elia, Ron Alcalay, et al.. (2019). Inhibition of Francisella tularensis phagocytosis using a novel anti-LPS scFv antibody fragment. Scientific Reports. 9(1). 11418–11418. 13 indexed citations
12.
Mechaly, Adva, Ron Alcalay, Tal Noy-Porat, et al.. (2018). Novel Phage Display-Derived Anti-Abrin Antibodies Confer Post-Exposure Protection against Abrin Intoxication. Toxins. 10(2). 80–80. 12 indexed citations
13.
Falach, Reut, Anita Sapoznikov, Ron Alcalay, et al.. (2018). Generation of Highly Efficient Equine-Derived Antibodies for Post-Exposure Treatment of Ricin Intoxications by Vaccination with Monomerized Ricin. Toxins. 10(11). 466–466. 10 indexed citations
14.
Alcalay, Ron, et al.. (2018). A bi-specific inhibitor targeting IL-17A and MMP-9 reduces invasion and motility in MDA-MB-231 cells. Oncotarget. 9(47). 28500–28513. 7 indexed citations
15.
Rosenfeld, Ronit, Ron Alcalay, Adva Mechaly, et al.. (2017). Improved antibody-based ricin neutralization by affinity maturation is correlated with slower off-rate values. Protein Engineering Design and Selection. 30(9). 611–617. 17 indexed citations
16.
Noy-Porat, Tal, Ron Alcalay, Eyal Epstein, et al.. (2017). Extended therapeutic window for post-exposure treatment of ricin intoxication conferred by the use of high-affinity antibodies. Toxicon. 127. 100–105. 17 indexed citations
17.
Noy-Porat, Tal, Ronit Rosenfeld, Naomi Ariel, et al.. (2016). Isolation of Anti-Ricin Protective Antibodies Exhibiting High Affinity from Immunized Non-Human Primates. Toxins. 8(3). 64–64. 35 indexed citations
18.
Gal, Yoav, Ron Alcalay, Tamar Sabo, et al.. (2015). Rapid assessment of antibody-induced ricin neutralization by employing a novel functional cell-based assay. Journal of Immunological Methods. 424. 136–139. 11 indexed citations
19.
Gal, Yoav, Ohad Mazor, Ron Alcalay, et al.. (2014). Antibody/doxycycline combined therapy for pulmonary ricinosis: Attenuation of inflammation improves survival of ricin-intoxicated mice. Toxicology Reports. 1. 496–504. 42 indexed citations
20.
Cohen, Ofer, Adva Mechaly, Tamar Sabo, et al.. (2014). Characterization and Epitope Mapping of the Polyclonal Antibody Repertoire Elicited by Ricin Holotoxin-Based Vaccination. Clinical and Vaccine Immunology. 21(11). 1534–1540. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joanne M. O’Hara Breakdown of academic impact, for papers by Hugh Haydon Breakdown of academic impact, for papers by Tal Noy-Porat Breakdown of academic impact, for papers by Audrey Y‐H. Teh Breakdown of academic impact, for papers by Julia Pinkhasov Breakdown of academic impact, for papers by Shuhei Hashiguchi Breakdown of academic impact, for papers by Lotte B. Westerhof Breakdown of academic impact, for papers by Bahne Stechmann Breakdown of academic impact, for papers by Kuo‐Shiang Liao Breakdown of academic impact, for papers by Hassan Chaabihi
Rankless by CCL
2026